Scientists hunt for clues to predict who benefits from targeted cancer drug
NCT ID NCT04257162
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study looks at tumor and blood samples from 180 people with metastatic cancer who have been treated with the drug trastuzumab deruxtecan (T-DXd). The goal is to find a specific genetic marker (ERBB2 mRNA level) that can predict how well a patient will respond to the drug. No new treatments are given; the study only collects and analyzes existing samples to improve future treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H.Univ. Arnau de Vilanova de Lleida
Lleida, Lleida, Spain
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
-
Hospital La Paz
Madrid, Madrid, 28046, Spain
-
Hospital Universitari Vall d' Hebron
Barcelona, Spain
-
Hospital Universitario 12 de octubre
Madrid, Spain
-
Hospital Universitario Virgen de la Arrixaca
Murcia, 30120, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Spain
-
Hospital Universitario de Canarias
Santa Cruz de Tenerife, Canary Islands, 38320, Spain
-
Hospital Universitario de Jerez
Jerez de la Frontera, Cadiz, 11407, Spain
-
Hospital Virgen de Macarena
Seville, Sevilla, Spain
-
Hospital Virgen de la Victoria
Málaga, Spain
-
Hospital del Mar
Barcelona, Barcelona, 08003, Spain
-
ICO Badalona
Badalona, Barcelona, Spain
-
ICO Hospitalet
Barcelona, Spain
-
Instituto Valenciano de Oncología (IVO)
Valencia, Valencia, 46009, Spain
Conditions
Explore the condition pages connected to this study.